SUN-448 Giant Prolactinomas: A Follow-Up of 25 Years with Dopamine Agonists

Giant prolactinomas are tumors with a large size > 4 cm and/or prolactin levels higher than 3000 ng/ml and/or highly invasive growth. Today dopamine agonists, mainly cabergoline (CAB), are the first-line choice in the treatment of these tumors. Objective: To assess the efficacy, safety and long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallea Gil, Susana, Diez, Sabrina, Stalldecker, Graciela, Palazzo, Adriana, Sosa, Maria de los Angeles, Telares, Noelia, Peressotti, Bruno, Ballarino, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553132/
http://dx.doi.org/10.1210/js.2019-SUN-448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553132/
http://dx.doi.org/10.1210/js.2019-SUN-448

Ejemplares similares